Market Tracker

12/07 11:17am ET

Pfizer Inc (NYSE:PFE)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
Trump warns Wall Street: I'm going to cut drug prices
10:40am / CNNMoney.com
Longest Winning Streak For Global Stocks On Monte Paschi Bailout Hopes, ECB Optimism
6:42am / Investing Channel - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
9:58am / Zacks.com - Paid Partner Content
Pfizer Takes $106 Million Fine from U.K. for Price Hike of Epilepsy Drug
6:39am / TheStreet.com - Paid Partner Content
Is Pfizer's New PD-L1 Drug a Game-Changer?
9:47am / MotleyFool.com - Paid Partner Content
Pfizer fined 84m for charging 'unfair' price for epilepsy drug
5:18am / FT.com - Paid Partner Content
Frontrunning: December 7
8:25am / Investing Channel - Paid Partner Content
The Latest Buzz in Biotech
Dec 06 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Pfizer
8:17am / MotleyFool.com - Paid Partner Content
Pfizer Leukemia Drug Meets Primary Endpoint in Phase III
Dec 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close--
Today’s open--
Day’s range-- - --
Volume--
Average volume (3 months)--
Market cap--
Dividend yield--
Data as of --

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.99%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio--
Price/Sales4.13
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
MRKMerck-1.28-2.12%
NVSNovartis-0.86-1.25%
SNYSanofi-0.54-1.33%
ABBVAbbVie-2.60-4.22%
Data as of 11:17am ET, 12/07/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.50
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts